ArticleOxidative medicine and cellular longevity2020

Apatinib, a Novel Tyrosine Kinase Inhibitor, Promotes ROS-Dependent Apoptosis and Autophagy via the Nrf2/HO-1 Pathway in Ovarian Cancer Cells.

Xiaodan Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.